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Abstract
Background: We tested the relevance of clinical information in the histopathologic evaluation of melanocytic skin neoplasm
(MSN).
Methods: Histopathologic specimens from 99 clinically atypical MSN were circulated among ten histopathologists; each
case had clinical information available in a database with a five-step procedure (no information; age/sex/location; clinical
diagnosis; clinical image; dermoscopic image); each step had a histopathologic diagnosis (D1 through D5); each diagnostic
step had a level of diagnostic confidence (LDC) ranging from 1 (no diagnostic certainty) to 5 (absolute diagnostic certainty).
The comparison of the LDC was employed with an analysis of variance (ANOVA) for repeated measures.
Findings: In D1 (no information), 36/99 cases (36.3%) had unanimous diagnosis; in D5 (full information available), 51/99
cases (51.5%) had unanimous diagnosis (p for difference between proportions ,0.001). The observer agreement expressed
as kappa increased significantly from D1 to D5. The mean LDC linearly increased for each observer from D1 through D5 (p
for linear trend ,0.001). On average, each histopathologist changed his initial diagnosis in 7 cases (range: 2–23). Most
diagnostic changes were in D2 (age/sex/location).
Interpretation: The histopathologic criteria for the diagnosis of MSN can work as such, but the final histopathologic
diagnosis is a clinically-aided interpretation. Clinical data sometimes reverse the initial histopathologic evaluation.
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Introduction
The histopathologic diagnosis of melanocytic skin neoplasms
(MSN) is often matter of considerable debate, even among
experienced histopathologists [1–3]. As a general rule, no clinical
information should ever reverse a histopathologic diagnosis when
the microscopic features are clear-cut. Nonetheless, basic clinical
information about any MSN (age and sex of patient; location of
the lesion) are required and commonly used [4] by histopathol-
ogists in their routine practice, particularly when approaching
peculiar MSN, such as early biopsied congenital naevi [5,6] and
spitzoid lesions [4,7]. Moreover, the existence of the so-called
‘special sites’ of MSN [8] clearly means that the location of the
lesions is another important diagnostic criterion. In recent years,
following the increasing use of dermoscopy (dermatoscopy,
epiluminescence microscopy, skin surface microscopy) for the
preoperative evaluation of MSN [9–14], several reports have
shown the positive influence of the dermoscopic features on the
histopathologic evaluation of MSN [15–19].
These results emphasize the value in studying whether clinical
history and clinical information would impact upon the histo-
pathologic diagnosis in dermatopathology [20].
We herein present the first study aimed at formally evaluating the
influenceofclinicaldatainroutinehistopathologicevaluationofMSN.
Methods
Study design
The goal of the present study was the evaluation of the
importance of the clinicopathologic correlation in the diagnosis of
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A panel of histopathologists received the respective microscopic
slides together with a database which gave them a sequential
access to clinical information for each case.
Clinical and histopathologic material
Two of us (GA and IZ) retrieved cases of skin neoplasms
consecutively excised from January 2004 to December 2005 for
routine histopathologic examination. Exclusion criteria were: a)
melanocytic naevi excised for cosmetic reasons; b) non-melano-
cytic lesions, as documented by the original histopathologic report.
Thus, only clinically and/or dermoscopically atypical MSN
entered the study. Each retrieved case had complete clinical
information, comprising digitized clinical and dermoscopic
images. The latter were JPEG-compressed files, 204861360 pixels
in size, 300 dpi in resolution, obtained using a digital camera
(Nikon Coolpix 995) coupled with Dermlite Foto lens (3-Gen,
Salvador Bay, Dana Point, CA, USA) for dermoscopic imaging.
One of the authors (GF) provided the original histologic
material of the selected cases and discussed them with a
histopathologist expert in dermoscopy (CM) in order to choose
for each case, a single paraffin block as being representative of the
given lesion. New haematoxylin-eosin stained microscopic slides
were prepared from the chosen blocks and again checked for their
technical as well as for their diagnostic adequacy.
Submission of clinical and histopathologic materials to further
diagnostic consultations was authorized by the patients or their
guardians.
Database preparation and functions
All the clinical information concerning the selected cases was
included into a FileMaker Pro 7
TM (FileMaker Inc.) generated
database. For each case a sequential access to the clinical
information was employed according to a five-step procedure,
with a diagnosis (D) given for each step:
D1: Diagnosis with no information available.
D2: Diagnosis with knowledge of age and sex of patient,
as well as location of the lesion.
D3: Diagnosis with knowledge of the clinical diagnosis,
as made in agreement by two of us (GA and IZ).
D4: Diagnosis with the clinical image available.
D5: Diagnosis with the dermoscopic image available
Case by case, from D1 through D5 the histopathologists were
asked to log into the database also a level of diagnostic confidence
(LDC), namely, the probability, as scored according to an
arbitrary scale, that they ‘subjectively’ attributed to the given
diagnosis [21]. The LDC scale was structured into five levels:
LDC 1 – No diagnostic certainty: no diagnosis can be
made.
LDC 2 – Low diagnostic certainty: a diagnosis is felt as
slightly more likely.
LDC 3 – Moderate diagnostic certainty: a diagnosis is
favoured, but with some elements of doubt.
LDC 4 – High diagnostic certainty: a diagnosis is
strongly favoured.
LDC 5 – Absolute diagnostic certainty: no other
diagnosis is possible.
Therefore, each case had five diagnoses (D1 through D5) and
each diagnosis had its LDC (ranging from 1 to 5).
Histopathology panelists
Ten histopathologists were invited to study the cases: among
these, five histopathologists had no specific experience in clinical
dermatology (ADB, EAAF, ON, CT, CU), whereas the other five
histopathologists did have clinical expertise (ZA, RC, LC, HK,
HPS). Two histopathologists with no clinical experience (ADB
and ON) and two histopathologists with clinical expertise (LC
and HPS) had previously worked at the same Institution for
several years; the other panelists had been never working in
cooperation.
Statistical Analysis
For statistical analysis, all the diagnoses were grouped into three
ratings: ‘melanoma’, ‘naevus’, and ‘unknown’. Consensus diagno-
sis was defined as a diagnosis made in agreement by at least seven
out of ten panelists, regardless the reported LDC.
Given n=10 as the number of panelists, the interobserver
agreement among the n(n21)/2=45 possible pairs of observers
was evaluated by using the k statistics introduced by Cohen [22].
The k statistics for multiple observers and the standard errors for
were calculated by using the method reported by Fleiss [23–25]: k
values range between +1 (perfect agreement) and 21 (perfect
disagreement); values greater than 0.75 represent an excellent
agreement; values lower than 0.40 a poor agreement; and values
between 0.40 and 0.75 a fair to good agreement beyond chance.
For the comparison of the LDC we used an analysis of variance
(ANOVA) for repeated measures. All given p-values are 2-tailed
and a p-value of ,0.05 indicates statistical significance.
A change of diagnosis during the stepwise examination of a
given case was defined as a switch from ‘naevus’ to ‘melanoma’ or
vice versa, or else, as a change from ‘unknown’ to either ‘naevus’
or ‘melanoma’.
Results
The study included 99 cases from 96 patients (M: F=0.6:1;
age range: 10–78 years; mean age: 43.3 years; median age: 42
years). Three patients had two lesions each which had been
excised in different times; the histopathology panelists were
unaware that these different lesions were from the same patients.
The most common location was the back (40 cases), followed by
the lower limbs (16 cases) and by the upper limbs (12 cases). The
original histopathologic diagnoses rendered by one of the
authors (GF) were ‘naevus’ in 54 cases and ‘melanoma’ in 45
cases.
Regardless the LDC, the study of the histopathologic specimens
alone (D1) gave a consensus diagnosis in 89/99 cases (89.9%), with
55 cases diagnosed as naevus and 34 cases as melanoma. Complete
agreement in D1 occurred in 36/99 cases (36.3%); of these, 17 were
diagnosed as naevus and 19 as melanoma. The k value for the
chance-corrected agreement in D1 was 0.57 (95% CI: 0.54–0.60).
The number of the consensus diagnoses in D5 increased only
slightly (91/99 cases [91.9%]) with 55 cases diagnosed as naevus
and 36 cases diagnosed as melanoma. Therefore, compared with
D1, two additional cases had a consensus diagnosis of melanoma
in D5. Both cases were lentiginous melanocytic proliferations of
the elderly. Figure 1 illustrates one of these cases. Complete
agreement in D5 strikingly increased to 51/99 cases (51.5%), with
24 cases diagnosed as naevus and 27 cases diagnosed as melanoma
(p for difference between proportions ,0.001). The k value
increased from D1 to D5 and reached 0.67 (95% CI: 0.64–0.70) in
D5 which is significantly higher than in D1. The number of cases
labeled as ‘‘unknown’’ by any of the observers decreased from 32
in D1 to one case in D5 (Table 1). Figure 2 shows a case in which a
Clinicopathologic Correlation
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procedure.
The mean LDC among all the panelists was 3.9 in D1 and 4.4
in D5. It increased in a linear fashion for each observer after each
step of additional information given (Figure 3). The increase in the
level of confidence was statistically significant for the whole group
(p for linear trend ,0.001).
The ten panelists gave a total of 990 diagnoses per step and
4950 diagnoses for the entire study. Table 2 itemizes the number
of changes of diagnosis following each step of clinical
information. Changes of diagnosis from D1 through D5
occurred in 87/4950 instances (1.75%). On average, each
observer changed his initial diagnosis in 7 cases (range of
changes: 2–23). Table 2 shows that most changes (49/87; 56.3%)
occurred in D2 (knowledge of age and sex of the patient and
location of the lesion), with a diagnostic switch into ‘naevus’ in
26 instances and into ‘melanoma’ in 22 instances. Overall, ten
out of 99 cases received more than one change of diagnosis in
D2. Five of these cases were lentiginous melanocytic prolifera-
tions (one of these cases is illustrated in Figure 1); three cases
were lesions with Spitz/Reed nevus-like features (one of these
cases is illustrated in Figure 2). The remaining two cases were
congenital nevi with an atypical junctional component (one of
these cases is illustrated in Figure 4).
Changes in D3 (clinical diagnosis), in D4 (clinical image), and in
D5 (dermoscopic image) occurred 8 (9.1%), 19 (21.8%), and 11
Figure 1. A 69-year-old man with a lesion from the back showing clinical (top left) and dermoscopic (top right) features of
regression [16]. Histopathologically, the lesion is medium to large in size and shows a regular epidermal hyperplasia (bottom left). The main feature
of atypia is the presence of areas of prevailing single cell proliferation at the junction (bottom right). Lentiginous melanocytic proliferations of the
elderly are often controversial from both a both conceptual and a practical point of view. The lesion at issue was diagnosed as melanoma in situ,
lentiginous type, [19] by six histopathologists in D1 and by eight histopathologists in D5.
doi:10.1371/journal.pone.0005375.g001
Table 1. Agreement (kappa) at every stage of diagnosis and number of ‘‘unknowns’’.
Overall Agreement
(Kappa) 95% CI
Agreement for
category nevus
(kappa) 95% CI
Agreement for
category
melanoma
(kappa) 95%CI
Category
’’Unknown’’ (n)
D1 0,57 0,54–0,60 0,58 0,43–0,74 0,63 0,51–0,76 32
D2 0,64 0,61–0,66 0,64 0,48–0,79 0,66 0,53–0,78 9
D3 0,65 0,62–0,67 0,64 0,49–0,80 0,67 0,54–0,79 7
D4 0,66 0,64–0,69 0,67 0,51–0,82 0,67 0,54–0,80 3
D5 0,67 0,64–0,70 0,67 0,51–0,83 0,67 0,54–0,80 1
doi:10.1371/journal.pone.0005375.t001
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dermoscopic images, 12 diagnoses were switched into ‘naevus’
and 18 diagnoses were switched into ‘melanoma’.
Discussion
The present study demonstrates that the histopathologic criteria
in the diagnosis of MSN can work as such, but the final diagnosis is
a clinically-aided interpretation. Clinical information can change
the histopathologic diagnosis in a number of cases.
Whether any diagnostic test should be read together with
clinical information has been debated since 1963, when Schreiber
[26] suggested that clinical information improved the accuracy of
chest X-ray evaluation. A commonly used argument against the
‘interdisciplinary’ approach is that clinical information may bias
the reading [20,27].
Very few studies have been carried out in cytohistopathology for
the evaluation of the diagnostic impact of the clinical information
[28,29]. However, several criteria routinely adopted for the
histopathologic diagnosis of MSN are implicitly based on
clinicopathologic correlation. Early biopsied congenital naevi can
show morphologic features – i.e.: proliferative nodules [5] and
pagetoid extension [6] – which, in a completely different clinical
context, would probably warrant a diagnosis of melanoma. A
trend has been observed in interpreting almost all spitzoid lesions
in children as ‘Spitz naevi’ and many spitzoid lesions in adults
(particularly beyond the age of 30 to 40 years) as melanoma [4,7].
There is a growing list of ‘special sites’ for naevi (acral skin, knees,
genital area, mammary region, cutaneous folds, nail matrix,
conjunctiva) [8]: MSN arising in these ‘special sites’ are
characterized by histopathologic features which could become
worrisome and favour the diagnosis of melanoma in ‘non-special
sites’.
It has been recently claimed that dermoscopy is the conceptual
and practical link between clinical dermatology (macrocosm) and
dermatopathology (microcosm) [9,14]. Like clinical dermatology,
dermoscopy works in parallel to the skin surface; like histopathol-
ogy, it allows to visualize structures which could not be discernible
by the naked eye. Dermoscopy can therefore draw the attention of
histopathologists to the suspicious areas of a given MSN [15] thus
orienting the macroscopic sampling and/or suggesting the need of
step-sectioning the paraffin block(s).
In the present study, most cases received a consensus diagnosis
(at least 7/10 diagnoses in agreement) even in the absence of any
clinical information. The chance-corrected interobserver agree-
ment expressed as Fleiss’ kappa was 0.57 even in this phase, and
largely overlapping with the results of the previously reported
studies on this topic [1–3]. The number of cases with a consensus
diagnosis, as well as the k statistics significantly higher when all the
clinical information were available, suggesting that the histopath-
ologic diagnosis can be improved by the clinical data.
Clinical data were important in order to increase the LDC and
this increase was statistically significant for all the observers
regardless of their clinical expertise. Clinical information may
influence microscopic observation at two stages: perception (identi-
fication of abnormal areas and their features) and interpretation
(attribution of the abnormalities to an entity). Mainstream
arguments state that clinical information, when evaluated before
the microscopic study, can influence both phases, therefore biasing
Figure 2. A 20-year-old woman with a lesion from the leg showing clinical (top left) and dermoscopic (top right) features consistent
with pigmented Spitz naevus [18]. Histopathology revealed a sharply circumscribed, medium-sized lesion which was mainly characterized by
nests of melanocytes at the junction (bottom left; haematoxylin-eosin,640). However, in some worrisome microscopic fields, melanocytes at all levels
of the epidermis were seen (bottom right; haematoxylin-eosin,6250). Due to these conflicting features, in the absence of any clinical information the
lesion was diagnosed as melanoma by three histopathologists and as naevus by seven histopathologists. With the knowledge of the complete clinical
information, the lesion was finally diagnosed as benign by all the histopathologists.
doi:10.1371/journal.pone.0005375.g002
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histopathologists can apply their criteria in the absence of any
clinical information (see above), and can therefore have an unbiased
perception of any given MSN. However, they feel more confident
with their diagnosis by means of a clinically-aided interpretation [30].
Ideally, the clinical course should allow inferring the biologic
potential of a given MSN. However, ‘malignancy’ not invariably
implies ‘metastasis’ and death’; this is why clinicopathologic studies
on MSN often refer to the histopathologic diagnosis as the ‘golden
standard’ [13]. However, based on the evaluation of the
histopathologic interobserver agreement, it was already demon-
strated that there is the need for a better standardization and
greater reproducibility in the histopathologic diagnosis of MSN
[1–3]. Therefore, the histopathologic diagnosis is not a true
‘golden standard’ but rather an ‘assessment of probability’: this means
that we should refer to the histopathologic report to as a
‘diagnostic proposal’ within a decision-making process. The latter
should incorporate, together with the ‘histopathologic diagnostic
proposal’, all pertinent clinical data, both from the patient
(personal history, age, sex, presence of clinically similar lesions)
and from the lesion under examination (location, history of
changes, clinical and dermoscopic features). We have adjusted the
design of the study to deal with the situation of a lack of a gold
standard (or practical reference standard). Since ‘‘correctness’’ is
not available we have chosen to look for indirect measures of the
quality of a diagnosis, namely, agreement of independent experts,
and confidence in the diagnosis. To minimize bias we have chosen
Table 2. Change of diagnosis following provision of clinical
information.
Diagnostic change Diagnostic information
D2 D3 D4 D5 Total
Into benign Unknown to naevus 1 41322 0
Melanoma to naevus 1 24432 3
Into malignant Unknown to melanoma 1 10101 2
Naevus to melanoma 11 3 11 6 31
Into unknown Nevus to unknown 0 0000
Melanoma to unknown 1 0001
Total 4 9 8 1 91 18 7
doi:10.1371/journal.pone.0005375.t002
Figure 3. The increase of the mean LDC for each histopathologist according to the diagnostic steps. On the horizontal axis: 1 – No
clinical information. 2 – Age and sex of the patient; location of the lesion. 3 – Clinical diagnosis. 4 – Clinical image. 5 – Dermoscopic image.
doi:10.1371/journal.pone.0005375.g003
Clinicopathologic Correlation
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together. This will not eliminate bias but it will minimize it.
It is even likely, albeit indemonstrable in the absence of a
practical reference standard, that the more histopathologists know
about a given MSN the higher the chance of a correct
histopathologic diagnosis. In the present study, we have at least
demonstrated that clinical information can improve the histopa-
thologists’ LDC, if not their own diagnosis. A LDC is currently not
provided in histopathologic reports. Nonetheless, in routine
practice any diagnostic decision is given by the balance between
certainty and uncertainty. Some recently introduced histopatho-
logic categories (superficial atypical melanocytic proliferation of
uncertain significance, S.A.M.P.U.S.; melanocytic tumor of
uncertain malignant potential, MEL.T.U.M.P.) [31] are basically
the expression of a low LDC. Clinicopathologic correlation could
probably raise the histopathologists’ LDC in some of these highly
controversial cases.
On average, in the stepwise examination of MSN each observer
changed his initial diagnosis in about 7 cases. This means that in
the course of the daily histopathologic examination of dozens of
MSN, clinical information can probably induce to change the
initial diagnosis in a substantial number of cases. In the present
study, most diagnostic changes occurred in D2 (with the
knowledge of the age and the sex of the patient and of the
location of the lesion). The low number of diagnostic changes does
not allow to draw any reliable conclusion, but we roughly assess
that there are at least three types of melanocytic lesions which are
particularly sensitive to clinical information, namely, lentiginous
melanocytic proliferations [19], Spitz/Reed nevus-like neoplasms
[4,7,18], and congenital nevi with atypical features.
As expected on the basis of the study selection criteria (i.e.:
clinically and/or dermoscopically atypical MSN), the majority of
the diagnostic switches in D4 (clinical image) and D5 (dermoscopic
image) were to melanoma (see Table 2). Interestingly, some
histopathologic diagnoses were switched into benignity after
studying images from clinically/dermoscopically atypical lesions
(see Table 2). We speculate that the very same submission of
clinical/dermoscopic images to histopathologists can stimulate a
critical re-evaluation of the histopathologic diagnosis just by
introducing a new step of microscopic observation following the
evaluation of clinical images.
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